The US Food and Drug Administration (FDA) has authorised a monoclonal antibody drug against COVID-19, developed by GlaxoSmithKline and Vir, which claims to reduce hospitalisation and death among Coronavirus patients by 85 per cent and is also effective against the variants.

US FDA authorises GSK-Vir monoclonal antibody drug for Covid

monoclonal-antibody-drug

Monoclonal Antibody Drug, News on Monoclonal Antibody Drug, stories on Monoclonal Antibody Drug, articles on Monoclonal Antibody Drug, Monoclonal Antibody Drug stories at Wion, Monoclonal Antibody Drug news, Monoclonal Antibody Drug latest news

monoclonal antibody-drug

US FDA authorises GSK-Vir monoclonal antibody drug for Covid